Anselamimab
Product Specifications
CAS Number
2414866-63-8
Target
Apolipoprotein|||Beta Amyloid
Related Pathways
Metabolism|||Neuroscience
Purity
0.98
Bioactivity
Anselamimab is a humanized IgG1? monoclonal antibody targeting serum amyloid A1 (SAA1) . It removes amyloid deposits by specifically binding to amyloid fibrils and triggering phagocytosis by macrophages and neutrophils.Anselamimab was used as an APP (?-amyloid A4 Protein Precursor) inhibitor in the clinical phase for the treatment of light chain (AL) amyloidosis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items